Medical and Pharmaceutical Johnson & Johnson may bankrupt a subsidiary to pay USD$6.9B talcum cancer settlements J&J plans to place a subsidiary into bankruptcy if at least 75 per cent of the talc claimants vote for its settlement proposal Joseph MortonAugust 28, 2024
Medical and Pharmaceutical United States appeals court rejects Johnson & Johnson tactic to avoid litigation The ruling opens J&J to further litigation for its failure to warn consumers about potential cancer risks with its talc-based products Joseph MortonJanuary 31, 2023